LGM Pharma Participates in DCAT Week 2015

LGM Pharma Participates in DCAT Week 2015

LGM Pharma Participates in DCAT Week 2015

DCAT Week is one of the largest gatherings in the world for the pharmaceutical and related industries.

NASHVILLE, Tennessee – Representatives from LGM Pharma, a leading supplier of active pharmaceutical ingredients to various global pharmaceutical firms, Headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, will participate in the Drug, Chemical & Associated Technologies (DCAT) Week in New York City March 10-13. During DCAT Week, LGM Pharma will meet with existing clients, network with new potential clients and keep themselves abreast of the newest industry trends.
The meeting brings industry CEO’s, presidents, global sales managers and directors of supply chain management from around the globe for high-level meetings, strategy sessions, education programs and networking events.
Member company representatives who participate in DCAT activities are involved in every aspect of the pharmaceutical manufacturing industry. They source or sell active pharmaceutical ingredients, contract manufacturing services, R&D services and drug delivery systems, as well as provide packaging or other manufacturing solutions.
According to Mendy Schurder, LGM Pharma COO, “At the same time that pharma is faced with the increased healthcare needs of an aging and expanding global population, it is also confronted with patent expirations, global economic risks, evolving manufacturing technologies, as well as difficult and potentially more costly new product launches. We will review the latest data that defines these challenges and explains how pharmaceutical companies are adapting their organizations, pipelines, marketing, and innovation strategies today and for the future.”
Through the support of over 350 member companies, DCAT (a non-profit organization) provides a range of unique services and programs designed to facilitate face-to-face networking and the sharing of knowledge and common interests.
“As a company using a consultative approach, LGM Pharma provides a seasoned perspective and a wealth of valuable insight that our clients’ both value and capitalize on,” states Robert Hoppes, LGM Pharma Director of Sales. “We focus on developing cutting-edge solutions that enable the pharmaceutical industry to realize significant qualitative and measurable cost and time benefits in the ‘drug discovery to market’ value chain. Our top priority is partnering with pharmaceutical companies in meeting the common objective of improving patient health. By attending technology conferences like DCAT Week, we can stay at the top of all the latest developments.”

About LGM Pharma
LGM Pharma is a leading supplier of active pharmaceutical ingredients (APIs) to Contract manufacturers and various global pharmaceutical firms involved in the manufacturing, research and development of a wide range of therapeutic chemical entities. In its commitment to improving health opportunities all over the world, LGM Pharma has forged partnerships with some of the biggest names in the pharmaceutical industry. Currently, the company supplies over 2,500 active pharmaceutical ingredients to its global clients.

  • Share:

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service